Senior corporate executive and investor focused on healthcare and consumer sectors, known for leading strategy, M&A and operational transformation. Annette M. Marshall brings leadership across private equity-backed and public companies, with board experience, capital-allocation oversight and growth execution. Background combines finance and operations with an MBA-level education; routinely advises management on scaling, cost optimisation, exit readiness and cross-border transactions.
Senior corporate executive and investor focused on healthcare and consumer sectors, known for leading strategy, M&A and operational transformation. Annette M. Marshall brings leadership across private equity-backed and public companies, with board experience, capital-allocation oversight and growth execution. Background combines finance and operations with an MBA-level education; routinely advises management on scaling, cost optimisation, exit readiness and cross-border transactions.
Combines an operationally-focused, value-oriented approach to investing in healthcare and consumer businesses. Prefers control or active minority positions where strategic and operational levers can accelerate revenue growth, margin expansion and exit value. Emphasizes rigorous diligence on commercial models, regulatory pathways and cross-border integration, and prioritizes disciplined capital allocation, milestone-based capital deployment and clear exit planning. Investment horizon is medium-to-long term, balancing growth investments with cost optimization and de-risking through staged financing and board-level governance to protect downside and maximize returns.
Combines an operationally-focused, value-oriented approach to investing in healthcare and consumer businesses. Prefers control or active minority positions where strategic and operational levers can accelerate revenue growth, margin expansion and exit value. Emphasizes rigorous diligence on commercial models, regulatory pathways and cross-border integration, and prioritizes disciplined capital allocation, milestone-based capital deployment and clear exit planning. Investment horizon is medium-to-long term, balancing growth investments with cost optimization and de-risking through staged financing and board-level governance to protect downside and maximize returns.
| Trades 1881 | Longs Won 1270/1881 67% | Profit Factor 7.85 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $5.4M |
| Average Win $781,375.4 | Best Trade (Jul 13) $172.96M | Sharpe Ratio -24.51 |
| Average Loss -$206,846.29 | Worst Trade (Mar 31) -$17.53M | Z-Score -11.39 (99.17%) |
| Commissions $0 | Avg. Trade Length 12m | Expectancy $460,374.09 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 14,493 | 13,043 | 11,594 | 10,145 | 8,696 | 7,246 | 5,797 | 4,348 | 2,899 | 1,449 |